Ono Pharmaceutical Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Ono Pharmaceutical Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Ono Pharmaceutical Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Ono Pharmaceutical Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Ono Pharmaceutical Co Ltd patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| US20230390303A1 | Application | Cancer treatment by combination of ep4 antagonist and immune checkpoint inhibitor | A61K31/337; A61K31/353; A61K31/4745; A61K31/506; A61K31/513; A61K31/519; A61K31/555; A61K31/7068; A61P35/00; C07K16/2827 | December 07, 2023 |
| JP7388635B2 | Grant | 免疫チェックポイント阻害薬の有効性判定バイオマーカー | A61K2039/507; A61K39/395; A61K45/00; A61P35/00; A61P35/02; A61P43/00; C07K16/2818; G01N2333/70514; G01N2333/70596; G01N2800/52; G01N33/48; G01N33/483; G01N33/505; G01N33/53; G01N33/574; G01N33/57492 | November 29, 2023 |
| EP4048659A4 | Search Report | Modulatoren der kanalfunktion von trek (TWIK-VERWANDTE K+-KANÄLE) | A61P11/00; A61P25/00; C07D231/16; C07D401/04; C07D401/12; C07D401/14; C07D405/04; C07D405/06; C07D405/14; C07D409/14; C07D413/06; C07D413/14; C07D417/14; C07D471/04 | November 29, 2023 |
| US11826363B2 | Grant | Therapeutic agent for solid cancers, which comprises axl inhibitor as active ingredient | A61K31/4709; A61K31/506; A61P35/00 | November 28, 2023 |
| ES2954717T3 | Grant | Antagonista de ep4 | A61K45/06; A61P37/00; A61P43/00; C07D209/08; C07D401/12; C07D403/12; C07D403/14; C07D405/12; C07D413/12; C07D417/12 | November 23, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer